Adiponectin in pulmonary disease and critically ill patients.

Adiponectin is a predominantly anti-inflammatory protein produced by adipose tissue with possible signalling activity in the lung. It is increasingly associated with inflammatory pulmonary diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and in critical illness. Although mouse studies indicate causative associations between adiponectin and asthma and COPD, the human literature in this regard is inconclusive. Some, but not all, studies demonstrate that serum adiponectin concentrations are inversely associated with asthma prevalence among premenopausal women and peripubertal girls. On the other hand, serum adiponectin concentrations are associated with lower asthma severity among boys but greater severity among men. Further, case-control studies demonstrate higher systemic and airway adiponectin concentrations in primarily male COPD patients than controls. Systemic adiponectin is positively associated with lung function in healthy adults but inversely associated in studies of male subjects with COPD. Murine and human studies further show contradictory associations of systemic adiponectin with critical illness. Higher premorbid systemic adiponectin concentrations are associated with improved survival from sepsis in mice. On the other hand, higher systemic adiponectin concentrations on day 1 of critical illness are associated with lower survival in critically ill patients with respiratory failure. In the absence of adequate longitudinal data, it is not possible to determine whether the adiponectin derangements are the consequence or the cause of the disease studied. Future research will determine whether modulation of adiponectin, independent of BMI, may be helpful in the prevention or treatment of asthma, COPD or critical illness.

[1]  S. Tufik,et al.  Interdisciplinary therapy improves biomarkers profile and lung function in asthmatic obese adolescents , 2012, Pediatric pulmonology.

[2]  A. Dixon,et al.  Relationship of Adipokines with Immune Response and Lung Function in Obese Asthmatic and Non-Asthmatic Women , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[3]  C. Lewis,et al.  Serum Adiponectin is Associated with Adverse Outcomes of Asthma in Men but Not in Women , 2011, Front. Pharmacol..

[4]  Jae-Won Oh,et al.  Serum leptin and adiponectin levels correlate with exercise-induced bronchoconstriction in children with asthma. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  T. Funahashi,et al.  Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. , 2011, American journal of respiratory and critical care medicine.

[6]  M. Quon,et al.  EFFECTS OF FENOFIBRATE THERAPY ON CIRCULATING ADIPOCYTOKINES IN PATIENTS WITH PRIMARY HYPERTRIGLYCERIDEMIA , 2011 .

[7]  A. Fitzpatrick,et al.  Airway and Plasma Leptin and Adiponectin in Lean and Obese Asthmatics and Controls , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[8]  M. Quon,et al.  Effects of simvastatin therapy on circulating adipocytokines in patients with hypercholesterolemia. , 2011, International journal of cardiology.

[9]  A. Sood Sex Differences: Implications for the Obesity-Asthma Association , 2011, Exercise and sport sciences reviews.

[10]  M. Quon,et al.  Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia. , 2011, Atherosclerosis.

[11]  D. Jacobs,et al.  Serum adiponectin is positively associated with lung function in young adults, independent of obesity: The CARDIA study , 2010, Respiratory research.

[12]  T. Rice,et al.  Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure* , 2010, Critical care medicine.

[13]  R. Alfenas,et al.  Effect of the diet components on adiponectin levels. , 2010, Nutricion hospitalaria.

[14]  D. Broide,et al.  Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[15]  M. Chan-yeung,et al.  Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[16]  I. Shimomura,et al.  Adiponectin deficiency promotes the production of inflammatory mediators while severely exacerbating hepatic injury in mice with polymicrobial sepsis. , 2010, The Journal of surgical research.

[17]  P. Gergen,et al.  Asthma control, adiposity, and adipokines among inner-city adolescents. , 2010, The Journal of allergy and clinical immunology.

[18]  A. Sood,et al.  Leptin, adiponectin, and asthma: findings from a population-based cohort study. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[19]  K. Kostikas,et al.  Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. , 2010, Respiratory medicine.

[20]  G. Van den Berghe,et al.  Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin , 2009, Critical care.

[21]  I. Hickman,et al.  Changes in serum adiponectin concentrations in critical illness: a preliminary investigation , 2009, Critical care.

[22]  T. Funahashi,et al.  Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. , 2009, Surgery.

[23]  R. Huupponen,et al.  Obesity, adipokines and asthma , 2009, Allergy.

[24]  S. Weiland,et al.  Associations of adipokines with asthma, rhinoconjunctivitis, and eczema in German schoolchildren , 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[25]  A. Sood,et al.  Effect of specific allergen inhalation on serum adiponectin in human asthma. , 2009, Chest.

[26]  P. Libby,et al.  Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. , 2009, American journal of respiratory cell and molecular biology.

[27]  S. Uh,et al.  Association of Serum Leptin and Adiponectin with Obesity in Asthmatics , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[28]  J. Ramsdell,et al.  Adiponectin and Functional Adiponectin Receptor 1 Are Expressed by Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease1 , 2009, The Journal of Immunology.

[29]  F. Karadağ,et al.  Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease , 2009, Scandinavian journal of clinical and laboratory investigation.

[30]  A. Meikle Adiponectin isoform distribution in women—relationship to female sex steroids and insulin sensitivity , 2009 .

[31]  Kyu-Earn Kim,et al.  Relationship between adipokines and manifestations of childhood asthma , 2008, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[32]  E. Karapanagiotou,et al.  The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). , 2008, Lung cancer.

[33]  M. Matsuda,et al.  Effects of sulfonylurea drugs on adiponectin production from 3T3-L1 adipocytes: implication of different mechanism from pioglitazone. , 2008, Diabetes research and clinical practice.

[34]  B. Suki,et al.  Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[35]  D. Jacobs,et al.  Association between asthma and serum adiponectin concentration in women , 2008, Thorax.

[36]  C. Mantzoros,et al.  Circulating Adiponectin Levels and Expression of Adiponectin Receptors in Relation to Lung Cancer: Two Case-Control Studies , 2008, Oncology.

[37]  Jianping Ye,et al.  Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. , 2007, American journal of physiology. Endocrinology and metabolism.

[38]  M. Quon,et al.  Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes. , 2007, Atherosclerosis.

[39]  T. Itoh,et al.  Elevated circulating plasma adiponectin in underweight patients with COPD. , 2007, Chest.

[40]  J. Frystyk,et al.  Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. , 2007, The Journal of clinical endocrinology and metabolism.

[41]  R. Chen,et al.  TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation. , 2007, American journal of hypertension.

[42]  K. Çağlar,et al.  Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome , 2007, Nephrology.

[43]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[44]  D. Tanné,et al.  Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[45]  S. Kihara,et al.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.

[46]  C. Meisinger,et al.  Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. , 2006, Journal of the American College of Cardiology.

[47]  A. Xu,et al.  Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. , 2006, The Journal of allergy and clinical immunology.

[48]  U. Müller-Ladner,et al.  The Potential of Adiponectin in Driving Arthritis1 , 2006, The Journal of Immunology.

[49]  E. Ford,et al.  Association between leptin and asthma in adults , 2006, Thorax.

[50]  L. Campbell,et al.  Human adiponectin binds to bacterial lipopolysaccharide. , 2006, Biochemical and biophysical research communications.

[51]  J. Schaack,et al.  Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid. , 2006, Endocrinology.

[52]  A. Więcek,et al.  Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension. , 2005, American journal of hypertension.

[53]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[54]  L. Campbell,et al.  The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. , 2005, European journal of endocrinology.

[55]  K. Herbst,et al.  Testosterone administration suppresses adiponectin levels in men. , 2005, Journal of andrology.

[56]  A. Imrich,et al.  Effect of leptin on allergic airway responses in mice. , 2005, The Journal of allergy and clinical immunology.

[57]  K. Ajuwon,et al.  Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[58]  H. Tilg,et al.  Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. , 2004, Biochemical and biophysical research communications.

[59]  N. Mete,et al.  Serum leptin levels in asthmatic children treated with an inhaled corticosteroid. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[60]  D. Jacobs,et al.  Serum adiponectin in young adults--interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. , 2004, Annals of epidemiology.

[61]  F. Darendeliler,et al.  Leptin: does it have any role in childhood asthma? , 2004, The Journal of allergy and clinical immunology.

[62]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  U. Kintscher,et al.  Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity , 2004, Circulation.

[64]  S. Kihara,et al.  Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages , 2004, Circulation.

[65]  M. Wulster-Radcliffe,et al.  Adiponectin differentially regulates cytokines in porcine macrophages. , 2004, Biochemical and biophysical research communications.

[66]  John A Wagner,et al.  Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.

[67]  R. Nagai,et al.  Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. , 2004, Biochemical and biophysical research communications.

[68]  K. Çağlar,et al.  Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria. , 2004, Endocrine.

[69]  H. Yoshimatsu,et al.  Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. , 2004, Hepatology.

[70]  P. Froguel,et al.  Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes , 2003, Journal of Biological Chemistry.

[71]  S. Toubro,et al.  Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[72]  K. Shimamoto,et al.  Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension , 2003, Hypertension.

[73]  P. Iyengar,et al.  Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. , 2003, Diabetes.

[74]  M. Matsuda,et al.  Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.

[75]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[76]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[77]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.